AI-generated analysis. Always verify with the original filing.
Picard Medical, Inc. issued a press release announcing financial results for the fiscal year ended December 31, 2025, reporting total revenue of $4.94 million, up 12.5% from $4.39 million in 2024, product revenue of $4.75 million, operating loss of $(13.3) million, and net loss of $(27.0) million. Cash, cash equivalents, and restricted cash totaled $11.5 million at year-end following $27.1 million in net financing proceeds.
Event Type
Disclosure
Mandatory
Variant
8-K
. Results of Operations and Financial Condition. On March 25, 2026, Picard Medical, Inc. (the “Company”) issued a press release announcing the Company’s financi
. Financial Statements and Exhibits. (d) Exhibits The following exhibits are being furnished herewith: Exhibit No. Description 99.1 Picard Medical, Inc. Press R
| Metric | Value | Basis |
|---|---|---|
| Revenue | $4.94 | |
| Product Revenue | $4.75 | |
| Rental Revenue | $0.19 | |
| Gross Margin | -4.1% | |
| Operating Loss | $-13.30 | |
| Net Loss | $-27.00 |